CrushSCI.com
145.4平均天数
116.5中位天数
19最短天数
400最长天数
1812025发文量

Paper Review Records

全部论文审稿周期

30 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接

87 天

mRNA‑Encoded Antibodies as a Powerful Arsenal Against Superbugs‐Induced Sepsis

作者
Shuchen Pei; Zhaofei Guo; Linlin Cheng; Mingxing Luo; Shan Guan; Lifeng Xu; Rui Liao; Qin Xiao; Wen Wu; Hao Zeng展开收起
作者单位
1. School of Chemistry and Chemical Engineering Chongqing University of Science and Technology Chongqing China; 2. Department of Pharmacy The Second Affiliated Hospital of Third Military Medical University Chongqing China; 3. National Engineering Research Center of Immunological Products Third Military Medical University Chongqing China; 4. Department of Pediatrics Ludwig‐Maximilians University Munich Germany; 5. Chongqing Key Laboratory of High Active Traditional Chinese Drug Delivery System, Chongqing Engineering Research Center of Pharmaceutical Sciences, Chongqing Medical and Pharmaceutical College Chongqing China展开收起
PDF源文件 DOI 网页
127 天

Small Molecule‐Mediated Nrf2 Activation as a Neuroprotective Approach in Multiple Sclerosis

作者
Arnav Borole; Kevin Boguszewski; Philip Furmanski; Nanjoo Suh展开收起
作者单位
1. Department of Chemical Biology, Ernest Mario School of Pharmacy, Rutgers The State University of New Jersey Piscataway New Jersey USA; 2. Graduate Program of Pharmaceutical Sciences, Ernest Mario School of Pharmacy, Rutgers The State University of New Jersey Piscataway New Jersey USA; 3. Rutgers Cancer Institute of New Jersey, Rutgers The State University of New Jersey New Brunswick New Jersey USA展开收起
PDF源文件 DOI 网页
75 天

Discovery of New Quinoxaline, Tetracyclic‐Quinoxaline, and Imidazo[2,1‐ a ]isoindole Derivatives as Potent Antibacterial Candidates Targeting DNA Gyrase and Topoisomerase IV With Molecular Modeling Simulations

作者
Ahmed Ragab; Mohga Basseem; Dina S. Aboul‐Magd; Juraj Kronek; Zuzana Kroneková展开收起
作者单位
1. Chemistry Department, Faculty of Science (Boys) Al‐Azhar University Nasr City Cairo Egypt; 2. Chemistry Department, Faculty of Science Galala University Galala City Suez Egypt; 3. Department for Biomaterials Research Polymer Institute of the Slovak Academy of Sciences Bratislava Slovakia; 4. Chemistry Department, Faculty of Science Al‐Azhar University (Girls) Nasr City Cairo Egypt; 5. Drug Radiation Research Department National Center for Radiation Research and Technology (NCRRT), Egyptian Atomic Energy Authority Cairo Egypt展开收起
PDF源文件 DOI 网页
124 天

Preclinical Evaluation of cRGD‐Functionalized Lipid–Polymer Hybrid Nanocarriers for Anti‐VEGF Gene Therapy in Triple‐Negative Breast Cancer

作者
Busra Cesur Ergun; Devrim Demir‐Dora展开收起
作者单位
1. Department of Medical Pharmacology, Faculty of Medicine Akdeniz University Antalya Turkiye; 2. Department of Gene and Cell Therapy, Health Sciences Institute Akdeniz University Antalya Turkiye展开收起
PDF源文件 DOI 网页
400 天

Oxopyrrolidine–Acylhydrazone Scaffolds as Dual Inducers of Autophagy and Ferroptosis in the Breast Cancer via JNK/Beclin‐1/GPX4 Regulation

作者
Monisha Yadav H. S.; Min Hee Yang; Omantheswara Nagaraja; Santosh L. Gaonkar; Shreeja Basappa; Mahendra Madegowda; Vladimir N. Nikolenko; Kanchugarakoppal S. Rangappa; Narasimha M. Beeraka; Basappa Basappa; Kwang Seok Ahn展开收起
作者单位
1. Laboratory of Chemical Biology, Department of Studies in Organic Chemistry University of Mysore, Manasagangotri Mysore Karnataka India; 2. Department of Science in Korean Medicine College of Korean Medicine Kyung Hee University Seoul Republic of Korea; 3. Department of Studies in Physics University of Mysore Mysore Karnataka India; 4. Manipal Institute of Technology, Manipal Academy of Higher Education Manipal India; 5. Department of Chemistry BITS‐Pilani Hyderabad Campus, Jawahar Nagar Medchal India; 6. Department of Studies in Physics University of Mysore, Manasagangotri Mysore India; 7. Department of Human Anatomy and Histology I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University) Moscow Russia; 8. Saveetha Institute of Basic Medical Sciences (SIBMS), Saveetha Institute of Medical and Technical Sciences Saveetha University Chennai Tamil Nadu India; 9. Department of Molecular Diagnostics and Vaccines SYENICA Biotech Limited Chennai (Madras) Tamil Nadu India展开收起
PDF源文件 DOI 网页
99 天

Exploiting Plasmodium Mitochondrial Pathways for Next‐Generation Antimalarial Drug Development: Prospects and Updates

作者
Rohit Nehra; Kuldeep Singh; Himmat Singh; Praveen Kumar Bharti; Suman Dhanda展开收起
作者单位
1. ICMR‐National Institute of Malaria Research Dwarka India; 2. Department of Biochemistry Kurukshetra University Kurukshetra India展开收起
PDF源文件 DOI 网页

FAQ

DRUG DEVELOPMENT RESEARCH审稿要多久?

截至2026-11-17,CrushSCI 收录了 DRUG DEVELOPMENT RESEARCH 的 30 篇完整审稿记录。最快一篇从收稿到录用用了 19 天(GPCR Precision in Addiction Also Requires Ligand, Exposure, and Phenotype Precision,2026-08-02 收稿,2026-08-21 录用),最慢一篇用了 400 天;平均 145.4 天,中位数 116.5 天。

Expert Matching · Case Demo

把投稿要求,转成可验证的期刊方案

说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。

我们会在半小时内回复。

CrushSCI 在线

客户询问

我是环境工程专业,需要一篇 SCI,希望 3 个月内见刊。没有基金,也没有大牛挂名,可以投哪些期刊?

CrushSCI回复

可以。先按 90 天时限做可行性筛选,同步查找无基金、无知名作者挂靠的典型论文案例,作为选刊依据。重点核对研究质量与期刊 scope。

拟题建议
《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》

样本口径2026 年最近 5 篇有效论文样本

平均审稿59.6 天

中位数65 天

Contact CrushSCI

联系 CrushSCI

留下手机号或微信号,我们将与你确认学术润色、结构优化或一对一辅导咨询需求。

我们会在半小时内回复。

当前选择:学术咨询服务

预留联系方式

也可以直接发送邮件至 leader@crushsci.com

手机号和微信号至少填写一项,仅用于本次咨询联系,不会公开。